Spots Global Cancer Trial Database for SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI
Official Title: Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Oligo-residual Intracranial Disease After First-line Third-generation EGFR Inhibitors: a Multicenter, Randomized Clinical Trial.
Study ID: NCT06020066
Study Description
Brief Summary: Despite the impressive response rate to third-generation EGFR-TKIs, resistance inevitably develops in most patients. Stereotactic radiotherapy plays a growing role in the management of patients with brain metastasis. This study aims to evaluate the efficacy and safety of stereotactic radiotherapy for oligo-residual intracranial disease after first-line third-generation EGFR Inhibitors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Contact Details
Name: Zhengfei Zhu, MD
Affiliation: Fudan University
Role: PRINCIPAL_INVESTIGATOR
Name: Xuwei Cai
Affiliation: Shanghai Chest Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Qian Chu
Affiliation: Tongji Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Xiaorong Dong
Affiliation: Wuhan Union Hospital, China
Role: PRINCIPAL_INVESTIGATOR
Name: Lin Wu
Affiliation: Hunan Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Rongrong Zhou
Affiliation: Xiangya Hospital of Central South University
Role: PRINCIPAL_INVESTIGATOR
Name: Guang Han
Affiliation: Hubei Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Hui Zhu
Affiliation: Shandong Cancer Hospital and Institute
Role: PRINCIPAL_INVESTIGATOR
Name: Jinjun Ye
Affiliation: Jiangsu Cancer Institute & Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Xiaojia Cui
Affiliation: The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
Role: PRINCIPAL_INVESTIGATOR
Name: Guomei Tai
Affiliation: The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
Role: PRINCIPAL_INVESTIGATOR
Name: Zhiyong Yuan
Affiliation: Tianjin Medical University Cancer Institute and Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Dejun XIng
Affiliation: Jilin Provincial Tumor Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jichen Ren
Affiliation: Jilin Provincial Tumor Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jiancheng Li
Affiliation: Fujian Medical University Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Yanyang Wang
Affiliation: General Hospital of Ningxia Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Chuangzhou Rao
Affiliation: Ningbo No.2 Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Bing Lu
Affiliation: The Affiliated Hospital Of Guizhou Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Zhongyi Dong
Affiliation: Nanfang Hospital, Southern Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Jiwei Liu
Affiliation: The First Affiliated Hospital of Dalian Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Zhenzhou Yang
Affiliation: The Second Affiliated Hospital of Chongqing Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Hongqing Zhuang
Affiliation: Peking University Third Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Anwen Liu
Affiliation: Nanchang University Second Affiliated Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Haihua Yang
Affiliation: Taizhou Hospital Affiliated to Wenzhou Medical University
Role: PRINCIPAL_INVESTIGATOR
Name: Fang Liu
Affiliation: Chinese PLA General Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Yong Mao
Affiliation: Affiliated Hospital of Jiangnan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
